JPY 8780.0
(-2.66%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 10.26 Billion JPY | 32.13% |
2023 | 7.76 Billion JPY | -2.16% |
2022 | 6.26 Billion JPY | -12.57% |
2021 | 7.74 Billion JPY | -15.91% |
2020 | 6.81 Billion JPY | -3.42% |
2019 | 8.96 Billion JPY | 19.03% |
2018 | 7.46 Billion JPY | 7.41% |
2017 | 6.86 Billion JPY | 29.66% |
2016 | 5.61 Billion JPY | 8.67% |
2015 | 5.2 Billion JPY | 20.47% |
2014 | 3.83 Billion JPY | -36.66% |
2013 | 6.83 Billion JPY | 112.45% |
2012 | 2.92 Billion JPY | 120.32% |
2011 | 1.31 Billion JPY | 42.69% |
2010 | 818.42 Million JPY | 89.26% |
2009 | 350.21 Million JPY | 10.84% |
2008 | 76 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1.08 Billion JPY | 530.0% |
2024 Q2 | 2.18 Billion JPY | -12.93% |
2024 Q3 | 3.21 Billion JPY | 61.26% |
2024 Q4 | 2.54 Billion JPY | 2.54% |
2023 Q2 | 815 Million JPY | 16.93% |
2023 Q1 | 697 Million JPY | 2.05% |
2023 FY | - JPY | -2.16% |
2023 Q4 | 185 Million JPY | -91.27% |
2023 Q3 | 2.12 Billion JPY | 160.12% |
2022 Q2 | 1.51 Billion JPY | 108.23% |
2022 FY | - JPY | -12.57% |
2022 Q1 | 729 Million JPY | -32.75% |
2022 Q4 | 683 Million JPY | -31.97% |
2022 Q3 | 1 Billion JPY | -33.86% |
2021 Q1 | 743 Million JPY | -80.29% |
2021 FY | - JPY | -15.91% |
2021 Q4 | 1.08 Billion JPY | -24.25% |
2021 Q3 | 1.43 Billion JPY | -25.51% |
2021 Q2 | 1.92 Billion JPY | 158.55% |
2020 Q1 | 1.4 Billion JPY | -37.68% |
2020 FY | - JPY | -3.42% |
2020 Q2 | 2.04 Billion JPY | 45.21% |
2020 Q3 | -694 Million JPY | -133.92% |
2020 Q4 | 3.77 Billion JPY | 643.23% |
2019 Q2 | 1.6 Billion JPY | 72.15% |
2019 FY | - JPY | 19.03% |
2019 Q4 | 2.26 Billion JPY | -4.8% |
2019 Q3 | 2.37 Billion JPY | 48.34% |
2019 Q1 | 930 Million JPY | -48.36% |
2018 Q1 | 461 Million JPY | -69.14% |
2018 Q3 | 1.97 Billion JPY | 28.69% |
2018 FY | - JPY | 7.41% |
2018 Q4 | 1.8 Billion JPY | -8.95% |
2018 Q2 | 1.53 Billion JPY | 233.41% |
2017 Q4 | 1.49 Billion JPY | -21.12% |
2017 FY | - JPY | 29.66% |
2017 Q3 | 1.89 Billion JPY | 52.13% |
2017 Q2 | 1.24 Billion JPY | 69.62% |
2017 Q1 | 734 Million JPY | -51.99% |
2016 FY | - JPY | 8.67% |
2016 Q3 | 985 Million JPY | 12.31% |
2016 Q1 | 298 Million JPY | -73.46% |
2016 Q4 | 1.52 Billion JPY | 55.23% |
2016 Q2 | 877 Million JPY | 194.3% |
2015 FY | - JPY | 20.47% |
2015 Q4 | 1.12 Billion JPY | -27.43% |
2015 Q1 | 206.63 Million JPY | -73.95% |
2015 Q2 | 660.41 Million JPY | 219.6% |
2015 Q3 | 1.54 Billion JPY | 134.29% |
2014 Q2 | 711.5 Million JPY | 209.38% |
2014 Q3 | 1.23 Billion JPY | 73.13% |
2014 FY | - JPY | -36.66% |
2014 Q1 | 229.97 Million JPY | -81.89% |
2014 Q4 | 793.07 Million JPY | -35.62% |
2013 Q2 | 2.41 Billion JPY | 84.09% |
2013 FY | - JPY | 112.45% |
2013 Q4 | 1.26 Billion JPY | 38.68% |
2013 Q3 | 915.67 Million JPY | -62.12% |
2013 Q1 | 1.31 Billion JPY | 30.19% |
2012 Q2 | 829.15 Million JPY | 366.88% |
2012 Q3 | 573.24 Million JPY | -30.86% |
2012 Q4 | 1 Billion JPY | 75.94% |
2012 FY | - JPY | 120.32% |
2012 Q1 | 177.59 Million JPY | -66.83% |
2011 Q2 | 659.24 Million JPY | 641.12% |
2011 Q1 | -121.82 Million JPY | -131.22% |
2011 Q3 | 434.02 Million JPY | -34.16% |
2011 Q4 | 535.38 Million JPY | 23.35% |
2011 FY | - JPY | 42.69% |
2010 Q4 | 390.26 Million JPY | 46.06% |
2010 Q3 | 267.18 Million JPY | -41.25% |
2010 FY | - JPY | 89.26% |
2010 Q1 | -56.21 Million JPY | -118.44% |
2010 Q2 | 454.8 Million JPY | 909.02% |
2009 Q4 | 304.87 Million JPY | 93.13% |
2009 Q1 | -120.1 Million JPY | 0.0% |
2009 Q2 | 215.36 Million JPY | 279.31% |
2009 Q3 | 157.85 Million JPY | -26.7% |
2009 FY | - JPY | 10.84% |
2008 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Medius Holdings Co., Ltd. | 3.86 Billion JPY | -165.599% |
Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 67.819% |
JTEC Corporation | 437.18 Million JPY | -2246.859% |
Hogy Medical Co.,Ltd. | 10.77 Billion JPY | 4.788% |
Kawamoto Corporation | 944.44 Million JPY | -986.349% |
Terumo Corporation | 219.66 Billion JPY | 95.329% |
KAINOS Laboratories, Inc. | 1.05 Billion JPY | -871.794% |
JAPAN EYEWEAR HOLDINGS CO LTD | 5.18 Billion JPY | -97.955% |
Sysmex Corporation | 115.67 Billion JPY | 91.13% |
JMS Co.,Ltd. | 3.44 Billion JPY | -197.737% |
Nakanishi Inc. | 32.3 Billion JPY | 68.236% |
Mani, Inc. | 10.69 Billion JPY | 4.103% |
Olympus Corporation | 180.16 Billion JPY | 94.305% |
HOYA Corporation | 260.44 Billion JPY | 96.061% |
SEED Co.,Ltd. | 4.88 Billion JPY | -110.222% |
Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 67.792% |
Medikit Co.,Ltd. | 6.31 Billion JPY | -62.346% |
Daiken Medical Co., Ltd. | 1.65 Billion JPY | -519.03% |
Menicon Co., Ltd. | 16.9 Billion JPY | 39.29% |
Sincere Co., LTD. | 391 Million JPY | -2524.041% |
Platz Co., Ltd. | 267.15 Million JPY | -3740.51% |
Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 56.171% |
Shofu Inc. | 5.87 Billion JPY | -74.549% |
Shigematsu Works Co., Ltd. | 1.38 Billion JPY | -640.663% |
Nipro Corporation | 81.2 Billion JPY | 87.366% |
ASO International, Inc. | 602.47 Million JPY | -1602.978% |